Extracellular NAD
5'-Nucleotidase
/ genetics
DNA Damage
DNA Repair
Gene Expression
Gene Expression Regulation, Neoplastic
Humans
MCF-7 Cells
Mitochondria
/ physiology
NAD
/ metabolism
Poly ADP Ribosylation
Poly(ADP-ribose) Polymerases
/ physiology
Reactive Oxygen Species
/ metabolism
Sirtuins
Tumor Microenvironment
/ genetics
X-ray Repair Cross Complementing Protein 1
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 01 2020
20 01 2020
Historique:
received:
14
08
2019
accepted:
29
12
2019
entrez:
22
1
2020
pubmed:
22
1
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Changes in nicotinamide adenine dinucleotide (NAD
Identifiants
pubmed: 31959836
doi: 10.1038/s41598-020-57506-9
pii: 10.1038/s41598-020-57506-9
pmc: PMC6971268
doi:
Substances chimiques
Reactive Oxygen Species
0
X-ray Repair Cross Complementing Protein 1
0
XRCC1 protein, human
0
NAD
0U46U6E8UK
Poly(ADP-ribose) Polymerases
EC 2.4.2.30
5'-Nucleotidase
EC 3.1.3.5
Sirtuins
EC 3.5.1.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
651Subventions
Organisme : NIEHS NIH HHS
ID : U01 ES029518
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES014811
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA148629
Pays : United States
Références
Kepp, O., Loos, F., Liu, P. & Kroemer, G. Extracellular nucleosides and nucleotides as immunomodulators. Immunol. Rev. 280, 83–92, https://doi.org/10.1111/imr.12571 (2017).
doi: 10.1111/imr.12571
pubmed: 29027229
Wilde, L. et al. Metabolic coupling and the R everse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Semin. Oncol. 44, 198–203, https://doi.org/10.1053/j.seminoncol.2017.10.004 (2017).
doi: 10.1053/j.seminoncol.2017.10.004
pubmed: 29248131
pmcid: 5737780
Otto, A. M., Hintermair, J. & Janzon, C. NADH-linked metabolic plasticity of MCF-7 breast cancer cells surviving in a nutrient-deprived microenvironment. J. Cell Biochem. 116, 822–835, https://doi.org/10.1002/jcb.25038 (2015).
doi: 10.1002/jcb.25038
pubmed: 25530451
Thongon, N. et al. Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA. Cancer Metab. 6, 1, https://doi.org/10.1186/s40170-018-0174-7 (2018).
doi: 10.1186/s40170-018-0174-7
pubmed: 29541451
pmcid: 5844108
Bogan, K. L. & Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115–130, https://doi.org/10.1146/annurev.nutr.28.061807.155443 (2008).
doi: 10.1146/annurev.nutr.28.061807.155443
pubmed: 18429699
Imai, S. & Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24, 464–471, https://doi.org/10.1016/j.tcb.2014.04.002 (2014).
doi: 10.1016/j.tcb.2014.04.002
pubmed: 24786309
pmcid: 4112140
Verdin, E. NAD(+) in aging, metabolism, and neurodegeneration. Science 350, 1208–1213, https://doi.org/10.1126/science.aac4854 (2015).
doi: 10.1126/science.aac4854
pubmed: 26785480
pmcid: 26785480
Sauve, A. A. NAD+ and vitamin B3: from metabolism to therapies. J. Pharmacol. Exp. Ther. 324, 883–893, https://doi.org/10.1124/jpet.107.120758 (2008).
doi: 10.1124/jpet.107.120758
pubmed: 18165311
Kennedy, B. E. et al. NAD(+) salvage pathway in cancer metabolism and therapy. Pharmacol. Res. 114, 274–283, https://doi.org/10.1016/j.phrs.2016.10.027 (2016).
doi: 10.1016/j.phrs.2016.10.027
pubmed: 27816507
Belenky, P., Bogan, K. L. & Brenner, C. NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12–19, https://doi.org/10.1016/j.tibs.2006.11.006 (2007).
doi: 10.1016/j.tibs.2006.11.006
pubmed: 17161604
Bruzzone, S. et al. A self-restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J. Biol. Chem. 276, 48300–48308, https://doi.org/10.1074/jbc.M107308200 (2001).
doi: 10.1074/jbc.M107308200
pubmed: 11602597
Gorelik, A., Randriamihaja, A., Illes, K. & Nagar, B. A key tyrosine substitution restricts nucleotide hydrolysis by the ectoenzyme NPP5. FEBS J. 284, 3718–3726, https://doi.org/10.1111/febs.14266 (2017).
doi: 10.1111/febs.14266
pubmed: 28898552
Hottiger, M. O. SnapShot: ADP-Ribosylation Signaling. Mol. Cell 62, 472, https://doi.org/10.1016/j.molcel.2016.04.019 (2016).
doi: 10.1016/j.molcel.2016.04.019
pubmed: 27153542
Chalkiadaki, A. & Guarente, L. The multifaceted functions of sirtuins in cancer. Nat. Rev. Cancer 15, 608–624, https://doi.org/10.1038/nrc3985 (2015).
doi: 10.1038/nrc3985
pubmed: 26383140
Fouquerel, E. & Sobol, R. W. ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death. DNA Repair. (Amst.) 23, 27–32, https://doi.org/10.1016/j.dnarep.2014.09.004 (2014).
doi: 10.1016/j.dnarep.2014.09.004
Fouquerel, E. et al. ARTD1/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion. Cell Rep. 8, 1819–1831, https://doi.org/10.1016/j.celrep.2014.08.036 (2014).
doi: 10.1016/j.celrep.2014.08.036
pubmed: 25220464
pmcid: 4177344
Goellner, E. M. et al. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res. 71, 2308–2317, https://doi.org/10.1158/0008-5472.CAN-10-3213 (2011).
doi: 10.1158/0008-5472.CAN-10-3213
pubmed: 21406402
pmcid: 3077901
van der Veer, E. et al. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J. Biol. Chem. 282, 10841–10845, https://doi.org/10.1074/jbc.C700018200 (2007).
doi: 10.1074/jbc.C700018200
pubmed: 17307730
Gong, B. et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models. Neurobiol. Aging 34, 1581–1588, https://doi.org/10.1016/j.neurobiolaging.2012.12.005 (2013).
doi: 10.1016/j.neurobiolaging.2012.12.005
pubmed: 23312803
pmcid: 3632303
Brown, K. D. et al. Activation of SIRT3 by the NAD(+) precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab. 20, 1059–1068, https://doi.org/10.1016/j.cmet.2014.11.003 (2014).
doi: 10.1016/j.cmet.2014.11.003
pubmed: 25470550
pmcid: 4940130
Gujar, A. D. et al. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc. Natl Acad. Sci. USA 113, E8247–E8256, https://doi.org/10.1073/pnas.1610921114 (2016).
doi: 10.1073/pnas.1610921114
pubmed: 27930300
Surjana, D., Halliday, G. M. & Damian, D. L. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J Nucleic Acids 2010, https://doi.org/10.4061/2010/157591 (2010).
doi: 10.4061/2010/157591
Almeida, G. S. et al. PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS. NMR Biomed 30, https://doi.org/10.1002/nbm.3736 (2017).
doi: 10.1002/nbm.3736
Clement, J., Wong, M., Poljak, A., Sachdev, P. & Braidy, N. The Plasma NAD(+) Metabolome Is Dysregulated in “Normal” Aging. Rejuvenation Res. 22, 121–130, https://doi.org/10.1089/rej.2018.2077 (2019).
doi: 10.1089/rej.2018.2077
pubmed: 30124109
pmcid: 6482912
Hassa, P. O. & Hottiger, M. O. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front. Biosci. 13, 3046–3082 (2008).
doi: 10.2741/2909
Ray Chaudhuri, A. & Nussenzweig, A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol. 18, 610–621, https://doi.org/10.1038/nrm.2017.53 (2017).
doi: 10.1038/nrm.2017.53
pubmed: 28676700
pmcid: 6591728
Posavec Marjanovic, M., Crawford, K. & Ahel, I. PARP, transcription and chromatin modeling. Semin. Cell & developmental Biol. 63, 102–113, https://doi.org/10.1016/j.semcdb.2016.09.014 (2017).
doi: 10.1016/j.semcdb.2016.09.014
Hottiger, M. O. Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics. Annu. Rev. Biochem. 84, 227–263, https://doi.org/10.1146/annurev-biochem-060614-034506 (2015).
doi: 10.1146/annurev-biochem-060614-034506
pubmed: 25747399
Kim, M. Y., Mauro, S., Gevry, N., Lis, J. T. & Kraus, W. L. NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119, 803–814, https://doi.org/10.1016/j.cell.2004.11.002 (2004).
doi: 10.1016/j.cell.2004.11.002
pubmed: 15607977
Doksani, Y. & de Lange, T. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining. Cell Rep. 17, 1646–1656, https://doi.org/10.1016/j.celrep.2016.10.008 (2016).
doi: 10.1016/j.celrep.2016.10.008
pubmed: 27806302
pmcid: 5125555
Fang, E. F. et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 157, 882–896, https://doi.org/10.1016/j.cell.2014.03.026 (2014).
doi: 10.1016/j.cell.2014.03.026
pubmed: 24813611
pmcid: 4625837
Scheibye-Knudsen, M. et al. A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome. Cell Metab. 20, 840–855, https://doi.org/10.1016/j.cmet.2014.10.005 (2014).
doi: 10.1016/j.cmet.2014.10.005
pubmed: 25440059
pmcid: 4261735
Fang, E. F. et al. NAD(+) Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair. Cell Metab. 24, 566–581, https://doi.org/10.1016/j.cmet.2016.09.004 (2016).
doi: 10.1016/j.cmet.2016.09.004
pubmed: 27732836
pmcid: 5777858
Braidy, N. et al. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. Antioxid. Redox Signal. 30, 251–294, https://doi.org/10.1089/ars.2017.7269 (2019).
doi: 10.1089/ars.2017.7269
pubmed: 29634344
Hou, Y. et al. NAD(+) supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc. Natl Acad. Sci. USA 115, E1876–E1885, https://doi.org/10.1073/pnas.1718819115 (2018).
doi: 10.1073/pnas.1718819115
pubmed: 29432159
Garten, A., Petzold, S., Korner, A., Imai, S. & Kiess, W. Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol. Metab. 20, 130–138, https://doi.org/10.1016/j.tem.2008.10.004 (2009).
doi: 10.1016/j.tem.2008.10.004
pubmed: 19109034
Drevs, J., Loser, R., Rattel, B. & Esser, N. Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma. Anticancer. Res. 23, 4853–4858 (2003).
pubmed: 14981935
Maldi, E. et al. Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. Pigment. Cell & melanoma Res. 26, 144–146, https://doi.org/10.1111/pcmr.12037 (2013).
doi: 10.1111/pcmr.12037
Garten, A. et al. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat. reviews. Endocrinol. 11, 535–546, https://doi.org/10.1038/nrendo.2015.117 (2015).
doi: 10.1038/nrendo.2015.117
Wang, P. & Miao, C. Y. NAMPT as a Therapeutic Target against Stroke. Trends Pharmacol. Sci. 36, 891–905, https://doi.org/10.1016/j.tips.2015.08.012 (2015).
doi: 10.1016/j.tips.2015.08.012
pubmed: 26538317
Hasmann, M. & Schemainda, I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 63, 7436–7442 (2003).
pubmed: 14612543
Watson, M. et al. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol. Cell Biol. 29, 5872–5888, https://doi.org/10.1128/MCB.00112-09 (2009).
doi: 10.1128/MCB.00112-09
pubmed: 19703994
pmcid: 2772749
Khan, J. A., Tao, X. & Tong, L. Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat. Struct. Mol. Biol. 13, 582–588, https://doi.org/10.1038/nsmb1105 (2006).
doi: 10.1038/nsmb1105
pubmed: 16783377
Galli, U. et al. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J. medicinal Chem. 56, 6279–6296, https://doi.org/10.1021/jm4001049 (2013).
doi: 10.1021/jm4001049
Holen, K., Saltz, L. B., Hollywood, E., Burk, K. & Hanauske, A. R. The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest. N. Drugs 26, 45–51, https://doi.org/10.1007/s10637-007-9083-2 (2008).
doi: 10.1007/s10637-007-9083-2
von Heideman, A., Berglund, A., Larsson, R. & Nygren, P. Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemother. Pharmacol. 65, 1165–1172, https://doi.org/10.1007/s00280-009-1125-3 (2010).
doi: 10.1007/s00280-009-1125-3
Grozio, A. et al. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. J. Biol. Chem. 288, 25938–25949, https://doi.org/10.1074/jbc.M113.470435 (2013).
doi: 10.1074/jbc.M113.470435
pubmed: 23880765
pmcid: 3764798
Billington, R. A. et al. Emerging functions of extracellular pyridine nucleotides. Mol. Med. 12, 324–327, https://doi.org/10.2119/2006-00075.Billington (2006).
doi: 10.2119/2006-00075.Billington
pubmed: 17380199
pmcid: 1829198
Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528–536, https://doi.org/10.1016/j.cmet.2011.08.014 (2011).
doi: 10.1016/j.cmet.2011.08.014
pubmed: 21982712
pmcid: 3204926
Bieganowski, P. & Brenner, C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117, 495–502, https://doi.org/10.1016/s0092-8674(04)00416-7 (2004).
doi: 10.1016/s0092-8674(04)00416-7
pubmed: 15137942
Trammell, S. A., Yu, L., Redpath, P., Migaud, M. E. & Brenner, C. Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk. J. Nutr. 146, 957–963, https://doi.org/10.3945/jn.116.230078 (2016).
doi: 10.3945/jn.116.230078
pubmed: 27052539
pmcid: 6879052
Bruzzone, S., Guida, L., Zocchi, E., Franco, L. & De Flora, A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. 15, 10–12, https://doi.org/10.1096/fj.00-0566fje (2001).
doi: 10.1096/fj.00-0566fje
pubmed: 11099492
Sociali, G. et al. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Oncotarget 7, 2968–2984, https://doi.org/10.18632/oncotarget.6502 (2016).
doi: 10.18632/oncotarget.6502
pubmed: 26658104
Garavaglia, S. et al. The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem. J. 441, 131–141, https://doi.org/10.1042/BJ20111263 (2012).
doi: 10.1042/BJ20111263
pubmed: 21933152
Jin, D. et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res. 70, 2245–2255, https://doi.org/10.1158/0008-5472.CAN-09-3109 (2010).
doi: 10.1158/0008-5472.CAN-09-3109
pubmed: 20179192
pmcid: 2883609
Beavis, P. A., Stagg, J., Darcy, P. K. & Smyth, M. J. CD73: a potent suppressor of antitumor immune responses. Trends immunology 33, 231–237, https://doi.org/10.1016/j.it.2012.02.009 (2012).
doi: 10.1016/j.it.2012.02.009
Allard, B., Turcotte, M. & Stagg, J. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer. Expert. Opin. therapeutic targets 18, 863–881, https://doi.org/10.1517/14728222.2014.915315 (2014).
doi: 10.1517/14728222.2014.915315
Koszalka, P. et al. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis. Int. J. Biochem. Cell Biol. 69, 1–10, https://doi.org/10.1016/j.biocel.2015.10.003 (2015).
doi: 10.1016/j.biocel.2015.10.003
pubmed: 26545615
Ratajczak, J. et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 7, 13103, https://doi.org/10.1038/ncomms13103 (2016).
doi: 10.1038/ncomms13103
pubmed: 27725675
pmcid: 5476803
Morandi, F. et al. Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD. Oncoimmunology 7, e1458809, https://doi.org/10.1080/2162402X.2018.1458809 (2018).
doi: 10.1080/2162402X.2018.1458809
pubmed: 30221054
pmcid: 6136872
Canto, C., Sauve, A. A. & Bai, P. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol. Asp. Med. 34, 1168–1201, https://doi.org/10.1016/j.mam.2013.01.004 (2013).
doi: 10.1016/j.mam.2013.01.004
Sykora, P. et al. Next generation high throughput DNA damage detection platform for genotoxic compound screening. Sci. Rep. 8, 2771, https://doi.org/10.1038/s41598-018-20995-w (2018).
doi: 10.1038/s41598-018-20995-w
pubmed: 29426857
pmcid: 5807538
Singh, N. P. The comet assay: Reflections on its development, evolution and applications. Mutat. Res. Rev. Mutat Res 767, 23–30, https://doi.org/10.1016/j.mrrev.2015.05.004 (2016).
doi: 10.1016/j.mrrev.2015.05.004
pubmed: 27036063
Pu, X., Wang, Z. & Klaunig, J. E. Alkaline Comet Assay for Assessing DNA Damage in Individual Cells. Curr. Protoc. Toxicol. 65(3 12), 11–11, https://doi.org/10.1002/0471140856.tx0312s65 (2015).
doi: 10.1002/0471140856.tx0312s65
Almeida, K. H. & Sobol, R. W. A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair. (Amst.) 6, 695–711, https://doi.org/10.1016/j.dnarep.2007.01.009 (2007).
doi: 10.1016/j.dnarep.2007.01.009
Roberts, E. L., Newton, R. P. & Axford, A. T. Plasma purine nucleoside phosphorylase in cancer patients. Clinica Chim. acta; Int. J. Clin. Chem. 344, 109–114, https://doi.org/10.1016/j.cccn.2004.02.008 (2004).
doi: 10.1016/j.cccn.2004.02.008
Ulanovskaya, O. A., Zuhl, A. M. & Cravatt, B. F. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol, https://doi.org/10.1038/nchembio.1204 (2013).
doi: 10.1038/nchembio.1204
Eckert, M. A. et al. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569, 723–728, https://doi.org/10.1038/s41586-019-1173-8 (2019).
doi: 10.1038/s41586-019-1173-8
pubmed: 31043742
pmcid: 6690743
Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1, https://doi.org/10.1126/scisignal.2004088 (2013).
doi: 10.1126/scisignal.2004088
pubmed: 23550210
pmcid: 4160307
Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery 2, 401–404, https://doi.org/10.1158/2159-8290.CD-12-0095 (2012).
doi: 10.1158/2159-8290.CD-12-0095
pubmed: 22588877
Spychala, J. et al. Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer. Clin. Cancer Res. 10, 708–717 (2004).
doi: 10.1158/1078-0432.CCR-0811-03
Chmielewski, J. P. et al. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD(+) Pools. Mol. Cancer Res. 16, 1687–1700, https://doi.org/10.1158/1541-7786.MCR-17-0526 (2018).
doi: 10.1158/1541-7786.MCR-17-0526
pubmed: 30076241
pmcid: 6214722
Yamamoto-Katayama, S. et al. Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities. J. Mol. Biol. 316, 711–723, https://doi.org/10.1006/jmbi.2001.5386 (2002).
doi: 10.1006/jmbi.2001.5386
pubmed: 11866528
Schmidt-Brauns, J. et al. Is a NAD pyrophosphatase activity necessary for Haemophilus influenzae type b multiplication in the blood stream? Int. J. Med. Microbiol. 291, 219–225, https://doi.org/10.1078/1438-4221-00122 (2001).
doi: 10.1078/1438-4221-00122
pubmed: 11554562
Kemmer, G. et al. NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in Haemophilus influenzae. J. Bacteriol. 183, 3974–3981, https://doi.org/10.1128/JB.183.13.3974-3981.2001 (2001).
doi: 10.1128/JB.183.13.3974-3981.2001
pubmed: 11395461
pmcid: 95280
Reidl, J. et al. NADP and NAD utilization in Haemophilus influenzae. Mol. Microbiol. 35, 1573–1581 (2000).
doi: 10.1046/j.1365-2958.2000.01829.x
Yang, Y., Mohammed, F. S., Zhang, N. & Sauve, A. A. Dihydronicotinamide riboside is a potent NAD(+) concentration enhancer in vitro and in vivo. J. Biol. Chem. 294, 9295–9307, https://doi.org/10.1074/jbc.RA118.005772 (2019).
doi: 10.1074/jbc.RA118.005772
pubmed: 30948509
Rahimova, R. et al. Identification of allosteric inhibitors of the ecto-5′-nucleotidase (CD73) targeting the dimer interface. PLoS Comput. Biol. 14, e1005943, https://doi.org/10.1371/journal.pcbi.1005943 (2018).
doi: 10.1371/journal.pcbi.1005943
pubmed: 29377887
pmcid: 5805337
Liu, L. et al. Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell Metab. 27, 1067–1080 e1065, https://doi.org/10.1016/j.cmet.2018.03.018 (2018).
doi: 10.1016/j.cmet.2018.03.018
pubmed: 29685734
pmcid: 5932087
Fletcher, R. S. et al. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Mol. Metab. 6, 819–832, https://doi.org/10.1016/j.molmet.2017.05.011 (2017).
doi: 10.1016/j.molmet.2017.05.011
pubmed: 28752046
pmcid: 5518663
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784, https://doi.org/10.1038/nmeth.3047 (2014).
doi: 10.1038/nmeth.3047
pubmed: 25075903
pmcid: 4486245
Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87, https://doi.org/10.1126/science.1247005 (2014).
doi: 10.1126/science.1247005
pubmed: 24336571
pmcid: 24336571
Nikiforov, A., Kulikova, V. & Ziegler, M. The human NAD metabolome: Functions, metabolism and compartmentalization. Crit. Rev. Biochem. Mol. Biol. 50, 284–297, https://doi.org/10.3109/10409238.2015.1028612 (2015).
doi: 10.3109/10409238.2015.1028612
pubmed: 25837229
pmcid: 4673589
Grozio, A. et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat. Metab. 1, 47–57, https://doi.org/10.1038/s42255-018-0009-4 (2019).
doi: 10.1038/s42255-018-0009-4
pubmed: 31131364
pmcid: 6530925
Hanzlikova, H., Gittens, W., Krejcikova, K., Zeng, Z. & Caldecott, K. W. Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin. Nucleic Acids Res. 45, 2546–2557, https://doi.org/10.1093/nar/gkw1246 (2017).
doi: 10.1093/nar/gkw1246
pubmed: 27965414
Gassman, N. R. & Wilson, S. H. Micro-irradiation tools to visualize base excision repair and single-strand break repair. DNA Repair. (Amst.) 31, 52–63, https://doi.org/10.1016/j.dnarep.2015.05.001 (2015).
doi: 10.1016/j.dnarep.2015.05.001
pmcid: 4458156
Holton, N. W., Andrews, J. F. & Gassman, N. R. Application of Laser Micro-irradiation for Examination of Single and Double Strand Break Repair in Mammalian Cells. Journal of visualized experiments: JoVE, https://doi.org/10.3791/56265 (2017).
Kulikova, V. A., Gromyko, D. V. & Nikiforov, A. A. The Regulatory Role of NAD in Human and Animal Cells. Biochem. (Mosc.) 83, 800–812, https://doi.org/10.1134/S0006297918070040 (2018).
doi: 10.1134/S0006297918070040
Zhang, N. & Sauve, A. A. Regulatory Effects of NAD(+) Metabolic Pathways on Sirtuin Activity. Prog. Mol. Biol. Transl. Sci. 154, 71–104, https://doi.org/10.1016/bs.pmbts.2017.11.012 (2018).
doi: 10.1016/bs.pmbts.2017.11.012
pubmed: 29413178
Sharif, T. et al. Regulation of Cancer and Cancer-Related Genes via NAD(). Antioxid. Redox Signal. 30, 906–923, https://doi.org/10.1089/ars.2017.7478 (2019).
doi: 10.1089/ars.2017.7478
pubmed: 29334761
Fessel, J. P. & Oldham, W. M. Nicotine Adenine Dinucleotides: The Redox Currency of the Cell. Antioxid. Redox Signal. 28, 165–166, https://doi.org/10.1089/ars.2017.7439 (2018).
doi: 10.1089/ars.2017.7439
pubmed: 29113451
pmcid: 5911702
Ostapkowicz, A., Inai, K., Smith, L., Kreda, S. & Spychala, J. Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. Mol. Cancer Ther. 5, 238–245, https://doi.org/10.1158/1535-7163.MCT-05-0226 (2006).
doi: 10.1158/1535-7163.MCT-05-0226
pubmed: 16505096
Turcotte, M. et al. CD73 is associated with poor prognosis in high-grade serous ovarian cancer. Cancer Res. 75, 4494–4503, https://doi.org/10.1158/0008-5472.CAN-14-3569 (2015).
doi: 10.1158/0008-5472.CAN-14-3569
pubmed: 26363007
VanLinden, M. R. et al. Subcellular Distribution of NAD+ between Cytosol and Mitochondria Determines the Metabolic Profile of Human Cells. J. Biol. Chem. 290, 27644–27659, https://doi.org/10.1074/jbc.M115.654129 (2015).
doi: 10.1074/jbc.M115.654129
pubmed: 26432643
pmcid: 4646015
Svilar, D., Goellner, E. M., Almeida, K. H. & Sobol, R. W. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid. Redox Signal. 14, 2491–2507, https://doi.org/10.1089/ars.2010.3466 (2011).
doi: 10.1089/ars.2010.3466
pubmed: 20649466
pmcid: 3096496
Masson, M. et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell Biol. 18, 3563–3571, https://doi.org/10.1128/mcb.18.6.3563 (1998).
doi: 10.1128/mcb.18.6.3563
pubmed: 9584196
pmcid: 108937
Breslin, C. et al. The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function. Nucleic Acids Res. 43, 6934–6944, https://doi.org/10.1093/nar/gkv623 (2015).
doi: 10.1093/nar/gkv623
pubmed: 26130715
pmcid: 4538820
Okano, S., Lan, L., Caldecott, K. W., Mori, T. & Yasui, A. Spatial and temporal cellular responses to single-strand breaks in human cells. Mol. Cell Biol. 23, 3974–3981, https://doi.org/10.1128/mcb.23.11.3974-3981.2003 (2003).
doi: 10.1128/mcb.23.11.3974-3981.2003
pubmed: 12748298
pmcid: 155230
Fang, Q. et al. HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase beta. Nat. Commun. 5, 5513, https://doi.org/10.1038/ncomms6513 (2014).
doi: 10.1038/ncomms6513
pubmed: 25423885
pmcid: 4246423
Park, M. J. et al. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res. 62, 6318–6322 (2002).
pubmed: 12414663
Ishii, N. et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9, 469–479 (1999).
doi: 10.1111/j.1750-3639.1999.tb00536.x
Stein, G. H. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J. Cell. Physiol. 99, 43–54, https://doi.org/10.1002/jcp.1040990107 (1979).
doi: 10.1002/jcp.1040990107
pubmed: 222778
Tang, J. B. et al. Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage. Mol. Cancer Res. 8, 67–79, https://doi.org/10.1158/1541-7786.MCR-09-0411 (2010).
doi: 10.1158/1541-7786.MCR-09-0411
pubmed: 20068071
pmcid: 2808464
Svilar, D. et al. Alkylation sensitivity screens reveal a conserved cross-species functionome. Mol. Cancer Res. 10, 1580–1596, https://doi.org/10.1158/1541-7786.MCR-12-0168 (2012).
doi: 10.1158/1541-7786.MCR-12-0168
pubmed: 23038810